Speakers

Shiraz University of Medical Sciences, Shiraz, Iran

*Section Head, hematological malignancies, Medical College of Wisconsin, Milwaukee, WI, USA

*Tulane Medical School Department of Internal Medicine, New Orleans, Louisiana,USA.

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

*Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio

*Division of Hematology and Oncology, University of California San Francisco

Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital, Washington DC, USA

Director, Cancer Vaccine Institute, University of Washington (UW), Seattle, WA, USA

UCLA Medical Center, Santa Monica, LA, USA

*Division of Internal Medicine and Haematology, University of Turin, Turin, Italy

Associate Vice President of Clinical Research, University of Texas M.D. Anderson Cancer Center

*Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa, FL, USA

National Institutes of Health, Bethesda, MD, USA

*Oncology University Hospitals Seidman Cancer Center, Cleveland, OH, USA.

Department of Biology, California State University Northridge (CSUN), Los Angeles, California

School of Medicine, Taylor’s University, Subang Jaya, Malaysia

RWTH Aachen University Hospital, Dental Materials and Biomaterials Research, Aachen, Germany

College of Medical & Dental Sciences, University of Birmingham, Birmingham , UK

Department of Pathology, Sant’Andrea University Hospital, Rome, Italy

University of Rijeka, Department of Biotechnology, Rijeka, Croatia

Houston Methodist Research Institute, Houston, USA

Department of Urologic Sciences, University of British Columbia, Vancouver, Canada

Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy

Unit of Clinical Pharmacology and Pharmacogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa

The University of Oklahoma Health Sciences Center, Oklahoma City, USA

Ex. Scientific Director, Regina Elena Institute (IRE), Rome, Italy

Yale School of Medicine, New Haven, CT, USA

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy

Director, (ORION), UT MD Anderson Cancer Center, Houston, TX, US

*Karmanos Cancer Institute, Wayne State School of Medicine, Detroit, Michigan.

IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy

Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, London, UK

University of Colorado, AMC Department of Pathology, Aurora, CO, US

School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

Tufts University, Medford, USA.

Universitat Autònoma de Barcelona, Barcelona, Spain

Sun Yat-sen University Cancer center, Guangzhou, China

Institute of Biostructures and Bioimaging (IBB), Italian National Research Council, Torino, Italy

Faculty of Medicine, University of Rome – Tor Vergata, Rome, Italy

Experimental Immunology Laboratory, IDI-IRCCS, Rome, Italy

Director, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, NY, USA

Medizinische Universität Innsbruck, Innsbruck, Austria

Polytechnic University of the Philippines, Philippines

Soochow University Institutes for Translational Medicine, China

Oncology Institute of Coimbra, Coimbra, Portugal

Department of Physics, Chuo University, Tokyo, Japan

Medical Director, Ruttenberg Treatment Center, Tisch Cancer Institute, Mount Sinai Hospital, NY, USA

Quillen College of Medicine, East Tennessee State University, Johnson City, US

School of Medicine, Faculty of Health & Medical Sciences, Taylor's University, Subang Jaya, Malaysia

Cell Biology Program Director, Mayo Clinic Cancer Center, Jacksonville, FL, USA